As per Bloomberg estimates, Sun Pharma's consolidated revenue for the March quarter is expected to rise 12.9% year-on-year to ...

Sun Pharmaceutical Industries Ltd. can launch its new hair-loss drug Leqselvi after the Federal Circuit reversed a district judge’s order granting Incyte Corp. an injunction blocking the release over ...

Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

The upside is due to a positive ruling by the US court regarding the launch of Leqselvi. The US Court heard arguments in the pharmaceutical company’s appeal against a previous decision by the ...

Planting seed money and “wishing” is not enough to claim “irreparable harm” to secure a preliminary injunction or to establish the standing required to appeal a patent board decision, the U.S. Court ...

Drugmaker Sun Pharma on Thursday said the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction effective immediately that thus far restricted the company from launching ...

Photograph: Francis Mascarenhas/Reuters Recent acquisitions, a favourable court ruling in the case of the hair loss drug Leqselvi, an edge over peers owing to its specialty portfolio, and a ...